Date/Time
Date(s) - 01/13/2014
4:00 pm
Abstract:
Economic and human resource barriers to developing an idea for a medical product in the academic lab to proof-of-concept are often minimal. Before proceeding toward the several further stages of required product development, it is wise to consider the potential for meeting extensive set of conditions to achieve a successful commercial outcome. Economic, technical, regulatory, corporate and many other considerations impact the ability to undertake and execute the product development plan. Case studies of a successful and unsuccessful medical product and of an academic to corporate technology transfer are provided in the presentation.
Short Bio:
Art Coury holds a B.S. degree in chemistry from the University of Delaware (1962), a Ph.D. in organic chemistry (1965) and an M.B.A. (1980) from the University of Minnesota. His industrial career included positions as: Senior Research Chemist at General Mills, Inc. (1965-1976), Director, Polymer Technology and Research Fellow at Medtronic, Inc. (1976-1993), Vice President, Research and Chief Scientific Officer at Focal, Inc. (1993-2000), and Vice President, Biomaterials Research at Genzyme Corporation (2000-June, 2008). He currently is a consultant. His career focus has been polymeric biomaterials for medical products such as implantable electronic devices, hydrogel-based devices and drug delivery systems. He holds over fifty distinct patents and has published and presented widely in his field. His teaching positions have included adjunct or affiliate appointments at the University of Minnesota, the Harvard-MIT Graduate Program in Health Sciences and Technology and the University of Trento, Italy. His professional service has included: Chair, Minnesota Section, American Chemical Society (1989-1990); President, Society for Biomaterials, USA (1999-2000); President, American Institute for Medical and Biological Engineering (AIMBE) (2003-2004) and membership on a number of university, society and corporate advisory boards. His recent recognitions have included the delivery of distinguished lectureships, receipt of the 2007 Innovation and Technology Development Award of the Society for Biomaterials, being named as one of “100 Notable People in the Medical Device Industry” by MD&DI magazine, 2008, induction into the National Academy of Engineering, USA, 2009, recognition on the University of Delaware alumni “Wall of Fame,” 2010, “The Man, the Myth, the Materials,” a symposium in honor of Art Coury’s 70th birthday, 2010, induction as an American Chemical Society Fellow, 2011, recipient of the Society for Biomaterials Founders’ Award, 2012 and its C. William Hall Award, 2013 , of the AIMBE Pierre Galletti award for 2012 and of the University of Minnesota Outstanding Alumni Award for 2013.